The Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market is poised for robust growth, driven by rising global incidence rates, breakthroughs in targeted and immunotherapies, and increasing adoption of biomarker-driven treatment strategies. With…
The Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market is poised for robust growth, driven by rising global incidence rates, breakthroughs in targeted and immunotherapies, and increasing adoption of biomarker-driven treatment strategies. With…